Table 2 Clinical characteristics of patients with and without LA/LAA thrombus

Male

110 (62.1%)

4 (80%)

n.s.

Female

67 (37.9%)

1 (20%)

n.s.

Age, mean

64.0 ± 8.8

68.8 ± 12.9

0.01

Mean ejection fraction

54.3 ± 6.0

48.6 ± 7.7

n.s.

Paroxysmal atrial fibrillation

116 (65.5%)

3 (60%)

n.s.

Persistent atrial fibrillation

61 (34.5%)

2 (40%)

n.s.

Cardiomyopathy (dilated)

9 (5.1%)

0 (0%)

n.s.

Mitral/aortic valve disease

27 (15.3%)

2 (40%)

n.s.

Serum creatinine; mg/dl

0.93 ± 0.27

1.12 ± 0.20

n.s.

Elevated serum creatinine

25 (14.1%)

2 (40%)

n.s.

CHADS 2

Congestive heart failure

33 (18.6%)

1 (20%)

n.s.

Hypertension

111 (62.7%)

4 (80%)

n.s.

Diabetes mellitus

30 (16.9%)

4 (80%)

0.0004

Prior stroke or TIA

7 (4.0%)

0 (0%)

n.s.

Age ≥ 75 years

12 (6.8%)

3 (60%)

<0.0001

CHADS2 = 0

41 (23.2%)

0 (0%)

n.s.

CHADS2 = 1

92 (52.0%)

0 (0%)

0.009

CHADS2 = 2

33 (18.6%)

3 (60%)

0.02

CHADS2 ≥ 3

11 (6.2%)

2 (40%)

0.004